Development of targeted nanocapsules using pomegranate peel extract with enhanced bioavailability and anti-inflammatory activity for ulcerative colitis: In vitro studies

The study aimed to establish an accurate drug delivery system with a tailored mechanism for the efficient management of Ulcerative Colitis (UC). Using the solvent evaporation technique, nanoencapsulation of pomegranate peel extract (PPE) in biodegradable enteric polymer methacrylic acid-ethyl acryla...

Full description

Saved in:
Bibliographic Details
Main Authors: P. Monika, M.N. Chandraprabha, R. Hari Krishna, Vittal Maanya, C. Likhitha, N. Pooja
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Hybrid Advances
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2773207X24001957
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850061713392533504
author P. Monika
M.N. Chandraprabha
R. Hari Krishna
Vittal Maanya
C. Likhitha
N. Pooja
author_facet P. Monika
M.N. Chandraprabha
R. Hari Krishna
Vittal Maanya
C. Likhitha
N. Pooja
author_sort P. Monika
collection DOAJ
description The study aimed to establish an accurate drug delivery system with a tailored mechanism for the efficient management of Ulcerative Colitis (UC). Using the solvent evaporation technique, nanoencapsulation of pomegranate peel extract (PPE) in biodegradable enteric polymer methacrylic acid-ethyl acrylate copolymer (Eudragit L-100) was prepared. In vitro drug release investigations indicated a greater percentage of drug released at 6.8 pH in contrast to 7.4 pH (96.98 ± 0.80 % vs. 93.97 ± 0.711 %), indicating its applicability in the region of the human intestine. The mechanism of drug release from the nanoformulations (NFR) exhibited a process controlled by Fickian diffusion. The results suggest efficient encapsulation of PPE within Eudragit L100 and may be used for targeted drug release in the intestinal region. Anti-inflammatory studies on the HIEC-6 cell line showed that tumour necrosis factor-α (TNF-α) expression was significantly (p < 0.001) decreased in all NFRs. Additionally, NFRs exhibited antioxidant activity and enhanced in vitro bioavailability (in intestinal pH compared to gastric pH).
format Article
id doaj-art-f6bcd172f8af48f1a135a6c962eedc72
institution DOAJ
issn 2773-207X
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Hybrid Advances
spelling doaj-art-f6bcd172f8af48f1a135a6c962eedc722025-08-20T02:50:08ZengElsevierHybrid Advances2773-207X2024-12-01710033410.1016/j.hybadv.2024.100334Development of targeted nanocapsules using pomegranate peel extract with enhanced bioavailability and anti-inflammatory activity for ulcerative colitis: In vitro studiesP. Monika0M.N. Chandraprabha1R. Hari Krishna2Vittal Maanya3C. Likhitha4N. Pooja5Department of Biotechnology, M.S. Ramaiah Institute of Technology (Affiliated to Visvesvaraya Technological University), MSR Nagar, MSRIT Post, Bangalore, 560054, India; Corresponding author.Department of Biotechnology, M.S. Ramaiah Institute of Technology (Affiliated to Visvesvaraya Technological University), MSR Nagar, MSRIT Post, Bangalore, 560054, India; Centre for Bio and Energy Materials Innovation, M.S. Ramaiah Institute of Technology (Affiliated to Visvesvaraya Technological University), MSR Nagar, MSRIT Post, Bangalore, 560054, India; Corresponding author. Department of Biotechnology, M.S. Ramaiah Institute of Technology (Affiliated to Visvesvaraya Technological University), MSR Nagar, MSRIT Post, Bangalore, 560054, India.Centre for Bio and Energy Materials Innovation, M.S. Ramaiah Institute of Technology (Affiliated to Visvesvaraya Technological University), MSR Nagar, MSRIT Post, Bangalore, 560054, India; Department of Chemistry, M.S. Ramaiah Institute of Technology (Affiliated to Visvesvaraya Technological University), MSR Nagar, MSRIT Post, Bangalore, 560054, India; Corresponding author. Centre for Bio and Energy Materials Innovation, M.S. Ramaiah Institute of Technology (Affiliated to Visvesvaraya Technological University), MSR Nagar, MSRIT Post, Bangalore, 560054, India.Department of Biotechnology, M.S. Ramaiah Institute of Technology (Affiliated to Visvesvaraya Technological University), MSR Nagar, MSRIT Post, Bangalore, 560054, IndiaDepartment of Biotechnology, M.S. Ramaiah Institute of Technology (Affiliated to Visvesvaraya Technological University), MSR Nagar, MSRIT Post, Bangalore, 560054, IndiaDepartment of Biotechnology, M.S. Ramaiah Institute of Technology (Affiliated to Visvesvaraya Technological University), MSR Nagar, MSRIT Post, Bangalore, 560054, IndiaThe study aimed to establish an accurate drug delivery system with a tailored mechanism for the efficient management of Ulcerative Colitis (UC). Using the solvent evaporation technique, nanoencapsulation of pomegranate peel extract (PPE) in biodegradable enteric polymer methacrylic acid-ethyl acrylate copolymer (Eudragit L-100) was prepared. In vitro drug release investigations indicated a greater percentage of drug released at 6.8 pH in contrast to 7.4 pH (96.98 ± 0.80 % vs. 93.97 ± 0.711 %), indicating its applicability in the region of the human intestine. The mechanism of drug release from the nanoformulations (NFR) exhibited a process controlled by Fickian diffusion. The results suggest efficient encapsulation of PPE within Eudragit L100 and may be used for targeted drug release in the intestinal region. Anti-inflammatory studies on the HIEC-6 cell line showed that tumour necrosis factor-α (TNF-α) expression was significantly (p < 0.001) decreased in all NFRs. Additionally, NFRs exhibited antioxidant activity and enhanced in vitro bioavailability (in intestinal pH compared to gastric pH).http://www.sciencedirect.com/science/article/pii/S2773207X24001957Pomegranate peel extractEudragit L-100Ulcerative colitisBioavailabilityTargeted drug deliveryAnti-inflammatory activity
spellingShingle P. Monika
M.N. Chandraprabha
R. Hari Krishna
Vittal Maanya
C. Likhitha
N. Pooja
Development of targeted nanocapsules using pomegranate peel extract with enhanced bioavailability and anti-inflammatory activity for ulcerative colitis: In vitro studies
Hybrid Advances
Pomegranate peel extract
Eudragit L-100
Ulcerative colitis
Bioavailability
Targeted drug delivery
Anti-inflammatory activity
title Development of targeted nanocapsules using pomegranate peel extract with enhanced bioavailability and anti-inflammatory activity for ulcerative colitis: In vitro studies
title_full Development of targeted nanocapsules using pomegranate peel extract with enhanced bioavailability and anti-inflammatory activity for ulcerative colitis: In vitro studies
title_fullStr Development of targeted nanocapsules using pomegranate peel extract with enhanced bioavailability and anti-inflammatory activity for ulcerative colitis: In vitro studies
title_full_unstemmed Development of targeted nanocapsules using pomegranate peel extract with enhanced bioavailability and anti-inflammatory activity for ulcerative colitis: In vitro studies
title_short Development of targeted nanocapsules using pomegranate peel extract with enhanced bioavailability and anti-inflammatory activity for ulcerative colitis: In vitro studies
title_sort development of targeted nanocapsules using pomegranate peel extract with enhanced bioavailability and anti inflammatory activity for ulcerative colitis in vitro studies
topic Pomegranate peel extract
Eudragit L-100
Ulcerative colitis
Bioavailability
Targeted drug delivery
Anti-inflammatory activity
url http://www.sciencedirect.com/science/article/pii/S2773207X24001957
work_keys_str_mv AT pmonika developmentoftargetednanocapsulesusingpomegranatepeelextractwithenhancedbioavailabilityandantiinflammatoryactivityforulcerativecolitisinvitrostudies
AT mnchandraprabha developmentoftargetednanocapsulesusingpomegranatepeelextractwithenhancedbioavailabilityandantiinflammatoryactivityforulcerativecolitisinvitrostudies
AT rharikrishna developmentoftargetednanocapsulesusingpomegranatepeelextractwithenhancedbioavailabilityandantiinflammatoryactivityforulcerativecolitisinvitrostudies
AT vittalmaanya developmentoftargetednanocapsulesusingpomegranatepeelextractwithenhancedbioavailabilityandantiinflammatoryactivityforulcerativecolitisinvitrostudies
AT clikhitha developmentoftargetednanocapsulesusingpomegranatepeelextractwithenhancedbioavailabilityandantiinflammatoryactivityforulcerativecolitisinvitrostudies
AT npooja developmentoftargetednanocapsulesusingpomegranatepeelextractwithenhancedbioavailabilityandantiinflammatoryactivityforulcerativecolitisinvitrostudies